NASDAQ$ZYXIQ

Zynex Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Zynex's financial results for Q4 and full year 2023 were reported, with FY 2023 revenue increasing 17% to $184.3 million and Q4 2023 revenue decreasing 3% year-over-year to $47.3 million.

Zynex reported a decrease in revenue for Q4 2023 to $47.3 million, a 3% decrease year-over-year, due to a $6.2 million non-recurring write-off. FY 2023 revenue increased 17% year-over-year to $184.3 million. The company's net income for Q4 2023 was $1.2 million, with diluted EPS of $0.04. The Board of Directors has approved an additional $20.0 million of the Company’s common stock.

  • FY 2023 revenue increased 17% year-over-year to $184.3 million; Q4 2023 revenue decreased 3% year-over-year to $47.3 million due to a $6.2 million non-recurring write-off of slow collecting receivables from a prior period which are booked as a charge against revenue.
  • FY 2023 net income of $9.7 million; Diluted EPS $0.27; Q4 2023 net income of $1.2 million; Diluted EPS $0.04.
  • FY 2023 orders increased 43% year-over-year; Q4 orders increased 29% year-over-year, the highest number of orders in Company history for the seventh consecutive quarter.
  • Company record FY 2023 cash flow from operations of $17.8 million, a 29% year-over-year increase.

Headline financials

Total Revenue

$47.3M

Previous: $48.8M-3.1%
EPS (adj)

$0.04

Previous: $0.20-80.0%
Adjusted EBITDA

$9.9M

No prior period
Capital Expenditures

-$576K

Previous: $86K-769.8%
Net Income

$1.2M

Previous: $7.5M-84.0%
Operating Income

$2.3M

Previous: $10.1M-77.3%
Gross Profit

$37M

Previous: $39.4M-6.1%
Stock-Based Comp

$675K

Previous: $640K+5.5%

Revenue & EPS history

Zynex · Revenue · Quarterly

$47.3M

Q4 2023-3.1%vs Q4 2022
Beat estimate in 7 of 16 quarters(44%)
ActualEstimate

Revenue by segment

Zynex · $49.9M total across 2 segments · Q3 2023

  • Supplies
    $33.1M
  • Devices
    $16.9M

Forward guidance

The Company expects 2024 net revenue of at least $227 million, a 23% increase from 2023. Diluted EPS is expected to be at least $0.50 per share, an 85% increase compared to 2023.

Tailwinds

  • Focus on new products.
  • Building on our holistic, non-invasive approach to pain management.
  • Expect 2024 net revenue to increase approximately 22% compared to 2023.
  • Part of our revenue growth will come from more aggressively promoting our bracing line of products as well as traction, cold/post-op and compression products.
  • Unique position to deliver solid revenue growth and profitability that allows us to invest in the business and return cash to shareholders at the same time.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+0.4%

Avg return

Earnings day

-1.8%

Avg return

5 days after

-6.5%

Avg return

30 days after

46%

29 / 63 earnings

Positive

+38.5%

Q3 2014

Best reaction

-51.6%

Q1 2010

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2024-51.3%
Q3 2025+0.0%+0.0%-98.2%
Q2 2025+0.0%+0.0%+0.0%
Q1 2025-25.6%+0.0%+0.0%
Q3 2024+9.1%+0.0%+0.0%
Q2 2024-11.4%+0.0%+0.0%
Q1 2024+2.8%+0.0%+0.0%
Q4 2023-8.8%+0.0%+0.0%
Q3 2023+17.5%+0.0%+0.0%
Q2 2023+3.3%+0.0%+0.0%
Q1 2023+2.5%+0.0%+0.0%
Q4 2022+16.7%+0.0%+0.0%
Q3 2022+15.0%+0.0%+0.0%
Q2 2022+13.3%+0.0%+0.0%
Q1 2022-8.6%+0.0%+0.0%
Q4 2021-1.7%+0.0%+0.0%
Q3 2021+10.0%+0.0%+0.0%
Q2 2021-19.3%+0.0%+0.0%
Q1 2021-9.2%-12.0%-6.3%
Q4 2020-21.2%-22.4%-18.8%
Q3 2020-6.5%
Q2 2020-6.0%
Q1 2020-1.1%
Q4 2019+3.1%
Q3 2019-7.9%
Q2 2019+9.8%
Q1 2019+7.9%
Q4 2018-11.1%
Q3 2018+3.4%
Q2 2018-3.3%
Q1 2018+4.5%
Q4 2017-20.7%
Q3 2017+6.6%
Q2 2017+34.6%
Q1 2017-5.6%
Q4 2016+9.7%
Q3 2016+23.1%
Q2 2016+34.8%
Q1 2016+0.0%
Q4 2015+0.0%
Q3 2015-4.3%
Q2 2015-5.4%
Q4 2014+0.0%
Q1 2015+0.0%
Q3 2014+38.5%
Q2 2014+2.2%
Q1 2014-0.2%
Q4 2013-3.6%
Q3 2013+13.6%
Q2 2013+7.1%
Q1 2013+0.0%
Q4 2012+3.4%
Q3 2012+5.6%
Q2 2012-5.1%
Q1 2012-6.3%
Q4 2011+0.0%
Q3 2010+12.9%
Q3 2011+12.9%
Q2 2011+1.1%
Q1 2011-8.2%
Q4 2010+0.0%
Q2 2010+2.0%
Q1 2010-51.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro